Related references
Note: Only part of the references are listed.The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
Aruz Mesci et al.
CLINICAL GENITOURINARY CANCER (2022)
Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials
Jonathan E. Leeman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer
Carlo Greco et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study
Carlo Greco et al.
FRONTIERS IN ONCOLOGY (2022)
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy
Michael J. Zelefsky et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer Results From the PROSINT Phase 2 Randomized Clinical Trial
Carlo Greco et al.
JAMA ONCOLOGY (2021)
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
Constantinos Zamboglou et al.
CANCERS (2021)
Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy
Carlo Greco et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review
Jim Zhong et al.
FRONTIERS IN ONCOLOGY (2021)
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
Dejan Kostyszyn et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT
Donald Fuller et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer
Ivan R. Vogelius et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Target motion mitigation promotes high -precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study
Carlo Greco et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer
Sarah Bergamin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Prostate re-irradiation: current concerns and future perspectives
Francesco Cuccia et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy
Carlo Greco et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy
Giuseppe Roberto D'Agostino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG
David Pasquier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Salvage Reirradiation using External Beam Radiotherapy for Local Failure in Prostate Cancer: A Systematic Review
M. T. Corkum et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Salvage reirradiation for local prostate cancer recurrence after I radiation therapy. For who? When? How?
M. Baty et al.
CANCER RADIOTHERAPIE (2019)
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)
Barbara Alicja Jereczek-Fossa et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy
Usman Bashir et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U. Kishan et al.
JAMA NETWORK OPEN (2019)
Clinical estimation of alpha/beta values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy
Niloy R. Datta et al.
ACTA ONCOLOGICA (2018)
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial
Antoine Kass-Iliyya et al.
EUROPEAN UROLOGY (2018)
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
Sebastian Zschaeck et al.
RADIATION ONCOLOGY (2018)
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference
Constantinos Zamboglou et al.
RADIATION ONCOLOGY (2018)
Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review
Thomas Feutren et al.
PROSTATE INTERNATIONAL (2018)
Predicting Biochemical Disease-Free survival after Prostate stereotactic Body radiotherapy: risk-stratification and Patterns of Failure
Alan Katz et al.
FRONTIERS IN ONCOLOGY (2016)
The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy
Zachary S. Zumsteg et al.
EUROPEAN UROLOGY (2015)
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer
Zachary S. Zumsteg et al.
JOURNAL OF UROLOGY (2015)
Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer
Anusha Kalbasi et al.
JAMA ONCOLOGY (2015)
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Cancer Control and Functional Outcomes of Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Systematic Review of the Literature
Daher C. Chade et al.
EUROPEAN UROLOGY (2012)
Twenty-Four-Month Postradiation Prostate Biopsies Are Strongly Predictive of 7-Year Disease-free Survival
Juanita M. Crook et al.
CANCER (2009)
Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer
Simona Marzi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer
Hui Wang et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer
Patrick A. Kupelian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Influence of local tumor control on distant metastases and cancer related mortality after external, beam radiotherapy for prostate cancer
Michael J. Zelefsky et al.
JOURNAL OF UROLOGY (2008)
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
Darko Pucar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome
Waseet Vance et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy
JF Fowler
ACTA ONCOLOGICA (2005)
Share Paper
